T 1492/09 (Antagonists of HMG1 for treating inflammatory conditions/FEINSTEIN) of 09.01.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T149209.20140109
- Date of decision
- 9 January 2014
- Case number
- T 1492/09
- Petition for review of
- -
- Application number
- 00915762.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Antagonists of HMG1 for treating inflammatory conditions
- Applicant name
- The Feinstein Institute for Medical Research
- Opponent name
- Alcedo Biotech GmbH
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 104(1)European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84Rules of procedure of the Boards of Appeal Art 16
- Keywords
- Main request - requirements of the EPC met (yes)
Apportionment of costs - (no) - Catchword
- -
- Cited cases
- G 0002/03
- Citing cases
- T 1602/10
Order
For these reasons it is decided that:
1. The request for apportionment of costs is dismissed.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the main request filed during oral proceedings and a description and figures to be adapted thereto.